tirzepatide and naltrexone together RETRACTED ARTICLE: Effect of combined GLP-1 analogue bupropion/ on weight loss: a retrospective cohort study Zepbound (Tirzepatide) for Weight Loss

Careful glucose monitoring is essential

Pregnant or Breastfeeding Women: The safety of semaglutide during pregnancy and lactation is not well studied

Across various non-clinical models, adverse effects have been limited and not widely reported, with most subjects tolerating the compound well

The authors conclude, "Tirzepatide represents an exciting avenue for future research into AD treatment, offering hope that this antidiabetic and anti-obesity agent could also help combat the growing burden of dementia." Reference: Alshehri, G.H., Al-kuraishy, H.M., Waheed, H.J

This information will help you and your provider better understand your risk factors so you can weigh them against the potential health benefits of tirzepatide

The SURMOUNT 2 trial revealed significant weight loss for tirzepatide, a glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide (GLP-1/GIP) dual receptor agonist, and makes the case for shifting from a glucose-centric approach to type 2 diabetes to a weight-centric one